Photo by nci from unsplash
Oxaliplatin, a third‐generation platinum derivative is commonly used in combination treatment of metastatic colorectal cancer. Since 2008, it is the second most common cause of drug‐induced immune hemolytic anemia (DIIHA)… Click to show full abstract
Oxaliplatin, a third‐generation platinum derivative is commonly used in combination treatment of metastatic colorectal cancer. Since 2008, it is the second most common cause of drug‐induced immune hemolytic anemia (DIIHA) investigated in our laboratory.
Keywords:
hemolytic anemia;
immune hemolytic;
induced immune;
drug induced
Journal Title: Transfusion
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!